Global Bio-chem Technology Group Company Limited
GBCMY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.02 | -0.00 |
| FCF Yield | 7.47% | 8.58% | -0.65% | 0.17% |
| EV / EBITDA | 72.43 | 89.51 | 50.48 | 1.56 |
| Quality | ||||
| ROIC | 1.88% | -2.96% | -7.37% | -6.12% |
| Gross Margin | 13.59% | 13.85% | 7.35% | 11.51% |
| Cash Conversion Ratio | -0.35 | 0.06 | 0.06 | 0.01 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.48% | -14.55% | -31.56% | -44.51% |
| Free Cash Flow Growth | -12.28% | 765.55% | -484.77% | 101.51% |
| Safety | ||||
| Net Debt / EBITDA | 60.50 | 75.38 | 37.37 | 1.25 |
| Interest Coverage | 0.14 | -0.25 | -0.72 | -0.23 |
| Efficiency | ||||
| Inventory Turnover | 3.74 | 4.62 | 2.76 | 4.24 |
| Cash Conversion Cycle | -99.45 | 48.74 | -46.50 | -57.96 |